Application of a new anticoagulant (Nafamostat Mesilate) to control hemorrhagic complications during extracorporeal membrane oxygenation-A preliminary report

Journal of Pediatric Surgery

Volumn 32, Issue 4, 1997, Pages 531-535

  Nagaya, Masahiro ^a   Futamura, Masahide ^a   Kato, Junji ^a   Niimi, Norihiro ^a   Fukuta, Sumio ^a  

^a Central Hospital   (Japan)

Author keywords

anticoagulant; Extracorporeal membrane oxygenation; hemorrhage

Indexed keywords

ANTICOAGULANT AGENT; HEPARIN; NAFAMSTAT MESILATE;

ANTICOAGULATION; ARTICLE; BLEEDING; CLINICAL ARTICLE; DOSE RESPONSE; ENZYME REGULATION; EXTRACORPOREAL OXYGENATION; HEPARINIZATION; HUMAN; HUMAN CELL; HUMAN TISSUE; INFANT; PRIORITY JOURNAL; PROTEINASE INHIBITION;

EID: 0030953579     PISSN: 00223468     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0022-3468(97)90701-6     Document Type: Article

References (23)

1. Bartlett RH, Gazzangia AB, Jefferies MR, et al: Extracorporeal membrane oxygenation (ECMO), cardiopulmonary support in infancy. Trans ASAIO 22:80-93, 1976
2. Bartlett RH, Toomasian J, Roloff D, et al: Extracorporeal membrane oxygenation (ECMO) in neonatal respiratory failure, 100 cases. Ann Surg 204:236-245, 1986
3. Stolar CJH, Snedecor SM, Bartlett RH: Extracorporeal membrane oxygenation and neonatal respiratory failure: Experience from the extracorporeal life support. J Pediatr Surg 26:563-571, 1991
4. Toomasian JM, Snedecor SM, Cornell RG, et al: National experience with extracorporeal membrane oxygenation for newborn respiratory failure. ASAIO 11:140-147, 1988
5. Neonatal ECMO Registry of the Extracorporeal Life Support Organization (ELSO), Ann Arbor, Michigan, July, 1995
6. Lally KP, Paranka MS, Roden J, et al: Congenital diaphragmatic hernia: Stabilization and repair on ECMO. Ann Surg 216:569-573, 1992
7. Teng CLC, Kim JS, Port FK, et al: A protamine filter for extracorporeal blood heparin removal. Trans ASAIO 34:743-746, 1988
8. Von Segessor LK, Turina M: Cardiopulmonary bypass without systemic heparinization. J Thorac Cardiovasc Surg 98:386-396, 1989
9. Mottaghy K, Oedekoven B, Poppel K, et al: Heparin free long-term extracorporeal circulation using bioactive surfaces. Trans ASAIO 35:635-637, 1989
10. Addonizio VP Jr, Fisher CA, Jenkin BK, et al: Iloprost (ZK3674), a stable analogue of prostacyclin, preserves platelets during simulated extracorporeal circulation. J Thorac Cardiovasc Surg 89:926-933, 1985
11. Wilson JM, Bower LK, Fackler JC, et al: Aminocaproic acid decreases the incidence of intracranial hemorrhage and other hemorrhagic complications of ECMO. J Pediatr Surg 28:536-541, 1993
12. Hitomi Y, Ikari N, Fujii S: Inhibitory effect of a new synthetic protease inhibitor (FUT-175) on the coagulation system. Haemostasis 15:164-168, 1985
13. Aoyama T, Ino Y, Ozeki M, et al: Pharmacological studies of FUT-175, Nafamostat mesilate, 1. Inhibition of protease activity in vitro and in vivo experiments. Jpn J Pharmacol 35:203-227, 1984
14. Miyamoto Y, Hirose H, Matsuda H, et al: Analysis of complement activation profile during cardiopulmonary bypass and its inhibition by FUT-175. Trans ASAIO 31:508-511, 1985
15. Hodohara K, Fujiyama Y, Hosoda S: Mechanism of the inhibitory effect of Nafamostat Mesilate (FUTHAN) on human platelet aggregation. Jpn Pharmacol Ther 15:597-606, 1987
16. Koshiyama Y, Ozeki M, Motoyoshi A, et al: Pharmacological studies of FUT-175, nafamostat mesilate. IV. Effects on coagulation, platelets and fibrinolysis. Folia Pharmacol Jpn 84:417-428, 1984
17. Koshikawa S, Akizawa T, Kazama M, et al: Clinical evaluation of FUT-175 as a regional anti-coagulant in hemodialysis. Multi center cooperative study. J Jpn Soc Dialysis Ther 20:951-953, 1987
18. Akizawa T, Koshikawa S, Iwamoto S, et al: Pharmacokinetic studies of regional anticoagulant - FUT175 - in hemodialysis. Kidney Dialysis 26:145-151, 1989
19. Okamoto T, Chung YK, Choi H, et al: Experimental results using Nafamostat Mesilate as anticoagulant during extracorporeal lung assist for 24 hours in dogs. Artif Organs 17:30-36, 1993
20. Yoshino Y, Kanazawa Y, Satoh S, et al: Experimental study of the anticoagulant on extracorporeal membrane oxygenation (ECMO) for newborn respiratory failure. J Jpn Soc Pediatr Surg 30:85-93, 1994
21. Takahama F, Kanai M, Hiraishi K, et al: Application of a prostacyclin analogue (PG) and protease inhibitor (FUT) as anticoagulants with an LVAD system. Trans ASAIO 32:253-258, 1986
22. Otsu T, Terasaki H, Morioka T: Experience of long term ECLA for 38 days in an infants with measles pneumonia. Jpn J Artif Organs 20:1124-1128, 1991
23. Kanazawa Y, Yoshino Y, Satoh S, et al: Extracorporeal membrane oxygenation using nafamostat mesilate as an anticoagulant. J Jpn Soc Pediatr Surg 31:191-197, 1995